
South Africa will start producing second generation vaccines to better fight the Covid-19 pandemic.
According to the South African-born billionaire, Patrick Soon-Shiong the vaccine production facility which opened here in the Mother City yesterday, would produce vaccines which would be far more capable in fighting the virus.
He says this new generation of vaccines are a lot more effective in disrupting the reproduction and further spread of the virus than currently available vaccines.
Soon-Shiong says the facility would also develop and produce therapies for the treatment of diseases such as cancer, HIV and tuberculosis.
Watch Dr. Soon-Shiong’s full briefing here.
Related articles:
- Vaccine production facility to boost South Africa’s Covid-19 fighting capabilities.
- Patrick Soon-Shiong’s cancer & Covid-19 vaccine initiative to significantly boost South Africa’s vaccine-manufacturing capabilities.
WATCH LIVE: President @CyrilRamaphosa launches the NantSA vaccine manufacturing campus with Dr Patrick Soon-Shiong, founder of NantWorks, LLC, at Brackengate in Cape Town. #InvestSA 🇿🇦 https://t.co/HAsg4DMPgS
— Presidency | South Africa 🇿🇦 (@PresidencyZA) January 19, 2022

President Cyril Ramaphosa says the vaccine production facility, unveiled in Brackengate yesterday, will tremendously boost South Africa’s Covid-19 fighting capabilities.
The plant, established by the US biotech billionaire Dr. Patrick Soon-Shiong, is set to produce a billion Covid-19 vaccine doses by 2025.
Ramaphosa says the facility would help provide much needed doses of vaccines to other African countries.
He says the establishment of the facility is also a big investment in the country’s scientific and research skills.
Watch the full media-briefing here.
Related articles:
- Patrick Soon-Shiong’s cancer & Covid-19 vaccine initiative to significantly boost South Africa’s vaccine-manufacturing capabilities.
- Dr. Patrick Soon-Shiong.
WATCH LIVE: President @CyrilRamaphosa launches the NantSA vaccine manufacturing campus with Dr Patrick Soon-Shiong, founder of NantWorks, LLC, at Brackengate in Cape Town. #InvestSA 🇿🇦 https://t.co/HAsg4DMPgS
— Presidency | South Africa 🇿🇦 (@PresidencyZA) January 19, 2022
Remarks by President @CyrilRamaphosa at the official launch of the Nant-SA Vaccine Manufacturing Campus, Brackengate Business Park, Brackenfel. https://t.co/NiTYfSw5dF#InvestSA pic.twitter.com/I4oCVk9JvV
— Presidency | South Africa 🇿🇦 (@PresidencyZA) January 19, 2022

President Cyril Ramaphosa says the new cancer and Covid-19 vaccine initiative, launched last week, will be a game-changer in South Africa’s fight against Covid-19.
Ramaphosa says the NantAfrica initiative, spearheaded by Dr. Patrick Soon-Shiong, will see the establishment of state-of-the-art vaccine production facilities in the country.
The initiative will also see the launch of the Centre for Epidemic Response and Innovation which will enhance rapid genomic surveillance of and response to viral mutations.
Follow the full briefing here.
Also read more here.
Related articles:
- Patrick Soon-Shiong’s cancer & Covid-19 vaccine initiative to significantly boost South Africa’s vaccine-manufacturing capabilities.
- WHO: Majority of people who get admitted to hospital for Covid-19 complications are unvaccinated.
- Light at the end of the tunnel for South Africa in its fight against Covid-19 pandemic.
[WATCH]: President @CyrilRamaphosa is the guest of honour at an announcement of an initiative ambitious initiative to build capacity for advanced health care in Africa by Dr Patrick Soon-Shiong, founder of the multinational conglomerate, NantWorks LLC. https://t.co/d5s7aq1WR3
— Presidency | South Africa 🇿🇦 (@PresidencyZA) September 23, 2021
Non-human primate study shows protection against SARS-CoV-2 challenge in lung and nasal passages. Special thanks to NIH/NIAID and ASPR/BARDA for their support on this important study. #COVID19 #Vaccine https://t.co/6CwjXonkd4
— ImmunityBio, Inc. (@ImmunityBio) September 17, 2021